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1  | INTRODUC TION
Social insects (ants, bees, wasps, and termites) are nearly ubiq‐
uitously distributed and ecologically very successful due to their 
advanced sociality including division of labor between castes and 
cooperation between individuals in a colony (Bourke & Franks, 
1995). Importantly, they form colonies that show reproductive 
division of labor between the reproductive queen(s) and the sterile 
workerforce, which help the queen reproduce. Social insect so‐
cieties are under particular threat of pathogens and disease, be‐
cause individuals in the colony usually are closely related offspring 
of the mother queen(s) and because the high number of individ‐
uals facilitates pathogen transmission (Schmid‐Hempel, 1998). 
Each individual is protected against disease by its own hygiene 
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Social insects have evolved enormous capacities to collectively build nests and de‐
fend their colonies against both predators and pathogens. The latter is achieved by a 
combination of individual immune responses and sophisticated collective behavioral 
and organizational disease defenses, that is, social immunity. We investigated how 
the presence or absence of these social defense lines affects individual‐level immu‐
nity	in	ant	queens	after	bacterial	infection.	To	this	end,	we	injected	queens	of	the	ant	
Linepithema humile	with	 a	mix	of	 gram+	and	gram−	bacteria	or	 a	 control	 solution,	
reared them either with workers or alone and analyzed their gene expression pat‐
terns	at	2,	4,	8,	and	12	hr	post‐injection,	using	RNA‐seq.	This	allowed	us	to	test	for	
the effect of bacterial infection, social context, as well as the interaction between the 
two over the course of infection and raising of an immune response. We found that 
social isolation per se affected queen gene expression for metabolism genes, but not 
for immune genes. When infected, queens reared with and without workers up‐regu‐
lated similar numbers of innate immune genes revealing activation of Toll and Imd 
signaling pathways and melanization. Interestingly, however, they mostly regulated 
different genes along the pathways and showed a different pattern of overall gene 
up‐regulation or down‐regulation. Hence, we can conclude that the absence of work‐
ers does not compromise the onset of an individual immune response by the queens, 
but that the social environment impacts the route of the individual innate immune 
responses.
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behavior and physiological immune system. Yet, in order to keep 
infections at bay, additional colony‐level defenses have evolved 
that consist of collectively performed hygiene behaviors and or‐
ganizational defenses, together forming the “social immunity” of 
the	colony	 (Cremer,	Armitage,	&	Schmid‐Hempel,	2007;	Evans	&	
Spivak, 2010).
Social immunity is employed to protect contaminated colony 
members from developing infections and to inhibit disease transmis‐
sion through the colony (Cremer, Pull, & Fürst, 2018). To this end, 
colonies of social insects perform intense nest hygiene, for exam‐
ple, by enriching their nest with antimicrobial material (Chapuisat, 
Oppliger, Magliano, & Christe, 2007; Christe, Oppliger, Bancalà, 
Castella, & Chapuisat, 2003; Simone, Evans, & Spivak, 2009), clean‐
ing their nestmates from infectious particles by grooming and chem‐
ical disinfection (Hughes, Eilenberg, & Boomsma, 2002; Rosengaus, 
Maxmen, Coates, & Traniello, 1998; Theis, Ugelvig, Marr, & Cremer, 
2015; Tragust, Mitteregger, et al., 2013), removing diseased brood 
from	 the	 nest	 (“hygienic	 behavior”;	 Rothenbuhler,	 1964;	 Tragust,	
Ugelvig, Chapuisat, Heinze, & Cremer, 2013; Ugelvig, Kronauer, 
Schrempf, Heinze, & Cremer, 2010), and performing destructive dis‐
infection to stop pathogen replication and to prevent disease trans‐
mission through the colony (Pull et al., 2018).
Proximately, these social immunity behaviors occur in re‐




aggression (Richard, Holt, & Grozinger, 2012). This suggests that 
nestmates can sense immune response, and in honeybees and 
ants, this has recently been shown to be mediated by cuticular 
hydrocarbons	 (Hernández	 López,	 Riessberger‐Gallé,	 Crailsheim,	
& Schuehly, 2017; Pull et al., 2018)—important cues for chem‐
ical communication in insects (Howard & Blomquist, 2005). 
Ultimately, all social immunity measures help to keep the colony 
free from disease, and to—in particular—prevent disease spread 
to the most valuable colony members, the reproductive queens 
(Cremer et al., 2018).
It has been suggested that these social immune measures may 
interfere with the evolution as well as expression of individual im‐
munity	(Barribeau	et	al.,	2015;	Evanset	al.,	2006;	Viljakainen	et	al.,	
2009), possibly reducing the need for individual immune responses. 
Most studies have focused on the analysis of the genome and im‐
mune components, where it was found that social insects have nei‐
ther strongly reduced nor enlarged immune repertoires (Barribeau 
et	al.,	2015;	Simola	et	al.,	2013),	and	all	major	insect	immune	path‐
ways	being	represented	(Toll,	Imd,	JAK/STAT,	JNK).	Recent	work	has	
shown that social, colony‐level pathogen defenses affect the func‐
tionality of individual‐level immune responses. In ants and honey‐
bees, exposure to resin, which has antibacterial properties and which 
these insects use as a nest building material, leads to decreased in‐
vestment in physiological immune response (Borba, Klyczek, Mogen, 
& Spivak, 2015; Castella, Chapuisat, Moret, & Christe, 2008; Simone 
et al., 2009).
The physiological immune defenses in insects comprise cellular 
and humoral responses, the former including phagocytosis of small 
microorganisms and encapsulation of larger parasites and the lat‐
ter composed of several signaling pathways that culminate in the 
production of antimicrobial peptides and other effector molecules 
(Ferrandon, Imler, Hetru, & Hoffmann, 2007). The core genes en‐
coding for these immune system components are retained across 
several	insect	orders	(Viljakainen,	2015).	Moreover,	the	immune	re‐
sponses are interconnected with stress responses, which in insects 
have an immune‐enhancing effect via stress hormones releasing 
energy	for	both	stress	and	immune	responses	(Adamo,	2017).	This	
interconnection may be particularly relevant for our study where we 
test the effect of worker presence or absence in the context of in‐
fection, as it is known that social isolation may induce stress and in‐
terfere with disease defense abilities in insects (Boulay, Quagebeur, 
Godzinska,	&	Lenoir,	1999;	Kohlmeier,	Holländer,	&	Meunier,	2016;	
Koto, Mersch, Hollis, & Keller, 2015).
While previous work has focused mostly on worker–worker 
interactions, we here test how ant queens, the most important in‐
dividuals of the colony, modulate their individual immune defenses 
after bacterial infection when they have access to social immunity 
or not (presence or absence of workers). We control for the fact 
of social isolation by also determining gene expression patterns of 
uninfected queens when alone or in the presence of their workers. 
We	used	queens	of	the	Argentine	ant	Linepithema humile (Figure 1) 
that	we	 injected	with	a	combination	of	gram+	and	gram−	bacte‐
ria or sterile saline solution and then kept in either isolation or 
with	workers.	After	injection,	changes	in	gene	expression	patterns	
were	 analyzed	 at	 four	 time	 points	 using	 RNA‐seq:	 shortly	 after	
injection	(2	hr),	during	the	development	of	the	 immune	response	
(4	 and	 8	hr	 post‐injection),	 and	when	 the	 immune	 response	was	
expected	to	be	fully	activated	(12	hr	post‐injection)	(Erler,	Popp,	&	
Lattorff,	2011).	We	hypothesized	that	both	the	infection	state	and	
the social environment will affect gene expression of the queens 
F I G U R E  1   Linepithema humile queen (on the left) and worker. 
Image	©	Alex	Wild,	used	by	permission
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and tested for an interaction between the two, in particular if the 
response to bacterial infection differed between the two rearing 
conditions.
2  | MATERIAL AND METHODS
2.1 | Samples
Workers	and	queens	of	 the	Argentine	ant	L. humile were collected 
from	the	European	main	supercolony	in	Castell	d’Aro,	Spain,	in	April	
2011 and kept in artificial nests in climate chambers (Sanyo) set to 
27°C for 14 hr of light and 21°C for 10 hr of dark. The ants were fed 
with	honey	and	cockroaches	three	times	per	week.	Approximately	
3 weeks prior to the experiments, small sub‐colonies originating 
from two stock colonies and each consisting of a single queen and 
10 workers were placed into petri dishes (diameter 9 cm) with a plas‐
tered ground and fed with 10% sugar water.
2.2 | Bacteria used for infections
We used the gram‐positive bacterium Staphylococcus aureus and the 
gram‐negative bacterium Serratia marcescens in combination for in‐
fecting the queens with the aim to induce gene expression of both 
Toll and Imd innate immune signaling pathways, since in Drosophila, 
gram‐positive bacteria are known to induce mainly the Toll path‐
way and gram‐negative bacteria the Imd pathway (Ferrandon et al., 
2007).	 The	bacteria	were	 grown	overnight	 in	 LB	medium	 (Merck).	
The bacterial suspension was centrifuged, and the pellet was washed 
three times in sterile saline solution (hereafter called Ringer) pre‐
pared	following	the	protocol	described	in	Aubert	&	Richard	(2008).	
The pellet from the final wash was suspended in Ringer. For the in‐
jections,	bacterial	suspensions	were	diluted,	bacterial	cells	counted	
using	Neubauer	counting	chamber,	and	S. marcescens and S. aureus 
dilutions mixed to get a solution representing both bacterial species 
in equal quantity.
2.3 | Injections and social environment
Linepithema humile queens were studied for effects on genomewide 
expression patterns at four time points (2, 4, 8, and 12 hr) after 
bacterial	 versus	 control	 injections	 in	 the	 presence	 or	 absence	 of	
five	workers	 in	a	full	factorial	design.	All	the	injections	were	made	
at the same time of day (in the morning) within a time window of 
3 hr. Sample information is summarized in Table 1. The queens 
were	randomly	assigned	for	either	bacterial	or	Ringer	injection	and	
were first transferred to small petri dishes on ice to cold‐immobilize 
them	for	 injection.	Microinjections	were	performed	using	Picoliter	
Injector	PLI‐100	Plus	(Harvard	Apparatus)	set	at	10	psi	for	1	s	using	
spiked glass needles with inner diameter of 11.9 μm (Biomedical 
Instruments),	 resulting	 in	 an	 injection	 volume	 of	 about	 65	nl.	 This	
volume	was	injected	twice	between	the	second	and	third	tergite	of	
the abdomen, containing approx. 1,300 bacterial cells (50:50 mix 
of S. marcescens and S. aureus).	 The	 controls	 were	 injected	 twice	
with	65	nl	of	sterile	Ringer.	After	injection,	the	queens	were	trans‐
ferred back to their original petri dish nests and kept together with 
five workers (social environment, the queens referred to as “social 
queens” hereafter) or reared alone by removing the workers (the 
queens referred to as “isolated queens” hereafter) at constant room 
temperature (22°C) and with 10% sugar water ad libitum. Each treat‐
ment at each time point was repeated three times.
2.4 | RNA extractions and sequencing
At	2,	4,	8,	or	12	hr	post‐injection	(hpi),	the	ants	were	frozen	in	liquid	
nitrogen	and	kept	in	−80°C	freezer	until	RNA	extraction.	The	whole‐
body	 samples	 were	 disrupted	 and	 homogenized	 in	 TissueLyser	 II	
(Qiagen)	using	stainless	steel	beads	(5	mm	diameter).	Total	RNA	was	
extracted	 using	RNeasy	Micro	Kit	 (Qiagen)	 following	 the	 protocol	
provided	with	the	kit	and	including	DNA	removal	using	RNase‐free	
DNase	 I.	RNA	was	quantified	using	Agilent	2100	Bioanalyzer,	 and	
the samples were sent to BGI Tech Solutions (Hong Kong) for library 
preparation	 (Illumina	TruSeq	RNA	Sample	Prep	Kit)	and	mRNA	se‐
quencing (100 bp paired‐end reads) with Illumina HiSeq2000.
2.5 | Bioinformatic analyses
The filtering of raw sequence data was performed by BGI and in‐
cluded adapter removal, removal of reads with more than 10% of un‐
determined bases, and removal of reads with more than 50% of low 
quality bases (Q < 10). Quality controlled clean data obtained from 
BGI were used for further analyses. The clean reads were mapped 
TA B L E  1   Sample information
Sample ID of biological 
replicatesa Injection Environment Timeb
B21, B37, B50 Bacteria S 2
B5, B29, B45 Bacteria S 4
B9, B41, B53 Bacteria S 8
B1, B17, B33 Bacteria S 12
B14, B22, B38 Bacteria I 2
B6,B30,	B46 Bacteria I 4
B26,	B42,	B49 Bacteria I 8
B2, B18, B55 Bacteria I 12
C15, C39,C52 Ringer S 2
C7, C47, C54 Ringer S 4
C11, C27, C43 Ringer S 8
C3, C35, C51 Ringer S 12
C16,	C24,	C40 Ringer I 2
C8, C32, C48 Ringer I 4
C12, C28, C57 Ringer I 8
C4,	C20,	C56 Ringer I 12
I: isolated; S: social.
aUnderlining indicates samples excluded from the analysis due to low 
mapping rate. bPost‐injection	time	point	(hours)	of	sample	collection.	
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to the L. humile reference	genome	(GCF_000217595.1)	using	STAR	





The count data of the samples were visualized by principal 
component	analysis	 (PCA)	 in	R	version	3.4.1	 (R	Core	Team,	2015).	
Analysis	of	differential	gene	expression	in	each	contrast	at	each	time	
point	was	carried	out	using	DESeq2	version	1.16.1	(Love,	Huber,	&	
Anders,	2014)	 in	R.	 In	DESeq2,	 the	 count	data	 for	 each	gene	 in	 a	
sample are modeled with a negative binomial distribution where the 
mean and dispersion are estimated from the data. The mean is the 
read count of a gene normalized by a size factor based on the me‐
dian of the ratios of observed counts (the read count of a gene in 
a given sample divided by the geometric mean of the read counts 
of that gene across all samples), thus allowing comparison of sam‐
ples with variable sequencing depth. The dispersion estimate is ob‐
tained by first estimating dispersion for each gene using maximum 
likelihood, then fitting a curve to the maximum likelihood estimates 
(MLEs),	and	finally,	shrinking	the	per	gene	dispersion	estimates	to‐
ward the expected dispersion values represented by the curve using 
empirical Bayes’ approach. Differential expression of a given gene 
between two conditions of interest is analyzed by using empirical 
Bayes	shrinkage	by	fitting	generalized	linear	model	(GLM)	to	obtain	
MLEs	for	log2	fold	change	(LFC)	between	the	conditions,	then	fitting	
normal distribution (µ	=	0)	 to	the	MLEs	of	all	genes,	and	repeating	
the	GLM	fit	for	the	given	gene	using	this	distribution	as	a	prior.	The	
maximum of the a posteriori distribution is the final estimate of the 
LFC,	and	the	curvature	of	the	distribution	at	its	maximum	is	the	stan‐
dard	error	of	the	LFC.	The	significance	of	the	LFCs	is	tested	by	Wald	
test, and the obtained p values are corrected for multiple testing by 
the	method	of	Benjamini	and	Hochberg	(1995).	In	this	study,	we	used	
a false discovery rate (FDR) <10%.
Insects, including L. humile,	are	known	to	harbor	RNA	viruses	
(Gruber	 et	 al.,	 2017;	 Shi	 et	 al.,	 2016)	which	may	have	 an	 effect	
on host gene expression (Doublet et al., 2017; Gerth & Hurst, 
2017). We studied whether viruses are present and potentially 
have an effect on the gene expression patterns by assembling 
all the reads that could not be mapped to the L. humile genome 
by using default settings in Trinity v2.5.1, and by doing database 
searches	with	 the	 obtained	 contigs	 against	National	 Center	 for	
Biotechnology	 Information	 (NCBI	Resource	Coordinators,	2017)	
RefSeq virus databases “viral.1.protein.faa” and “viral.2.protein.
faa”	 (accessed	7	January	2018)	using	BLASTX	2.6.0+	with	an	e‐
value threshold of 10−4. Contigs that matched insect viruses and 
that had a query coverage of at least 400 amino acids were used 
in the following steps. The unmapped reads from each sample 
were mapped against the selected blast‐annotated virus con‐
tigs	 using	 default	 settings	 in	 BWA‐MEM	 v.0.7.17	 (Li	 &	 Durbin,	
2009), and the mapped reads were counted using samtools v1.4 
(Li	et	al.,	2009)	and	normalized	with	the	sum	of	genome‐mapped	
and virus‐mapped reads per sample. The resulting viral load 
per sample was ordered by magnitude, divided into three equal 
sized bins, and classified as low (normalized read count range 
4.27 × 10−5–4.45 × 10−4, n = 14), medium (normalized read count 
range	 4.64	×	10−4–1.38 × 10−3, n	=	16),	 or	 high	 (normalized	 read	
count	 range	 2.16	×	10−3–0.18, n = 14). The virus load classifica‐
tion was incorporated as a factor in the analysis of differential 
gene expression.
A	list	of	manually	annotated	immune	genes,	hereafter	called	“the	
core immune genes”, of the L. humile genome including key genes 
for	 the	main	signaling	pathways	Toll,	 Imd,	 JAK‐STAT,	and	JNK	and	
additionally, genes involved in pathogen recognition, modulation of 
immune	 response,	 melanization,	 RNA	 interference,	 and	 clearance	
of	microbes	 (antimicrobial	 peptides	 and	 phagocytosis;	 Viljakainen,	
2015),	was	 retrieved	 from	Smith	et	 al.	 (2011),	 Table	S16.	Thirteen	
C‐type lectins, nine scavenger receptors, two Toll‐like proteins, 
and transferrin were added to the list, which now totaled 121 im‐
mune genes. These immune genes were searched against the list 
of differentially expressed genes (DEGs). Predicted function for 
all the other DEGs outside the core immune genes was searched 
using	PaperBLAST	(Price	&	Arkin,	2017)	and	NCBI	databases	(NCBI	
Resource Coordinators, 2017).
A	 BED	 formatted	 file	 was	 parsed	 from	 the	 NCBI	 L. humile 
Annotation	Release	100.	The	parsed	BED	file	included	the	coding	
sequence (CDS) coordinates for genes, exon coordinates for non‐
coding	RNAs,	and	exon	coordinates	for	some	other	genes	without	
CDS	annotation,	excluding	210	pseudogenes	and	46	tRNA	genes,	
and merging overlapping CDS and exon regions. Based on the ge‐
nomic coordinates in the BED file, the CDS or exon sequences 
were retrieved from the genome and concatenated for each 
gene	 in	FASTA	format.	This	 resulted	 in	 total	of	12,696	gene	se‐
quences. Gene Ontology (GO) annotation was carried out for the 
12,696	genes	using	Blast2GO	version	3.3.5	(Conesa	et	al.,	2005).	
First,	BLASTX	search	was	done	with	an	E‐value of 10−25 against 
all	 ant	 sequences	 in	 the	NCBI	non‐redundant	database	 restrict‐
ing	 the	 number	 of	 BLAST	 hits	 to	 20.	 In	 addition,	 InterProScan	
annotation was run for the sequences (Jones et al., 2014). For 
the resulting hits, GO mapping and annotation were performed 
and InterProScan GOs were merged to annotation. The first step 
resulted	 in	 9,406	 sequences	with	GO	 annotations.	Next,	 a	 sec‐
ond	round	of	BLASTX	search	was	done	with	the	sequences	that	
remained without hits in the first step with an E‐value of 10−25 
against	all	arthropod	sequences	in	the	NCBI	non‐redundant	data‐
base	restricting	the	number	of	BLAST	hits	to	100.	Again,	mapping	
and annotation were run for the resulting hits and InterProScan 
GOs	 were	 merged	 to	 the	 annotations.	 After	 the	 second	 step,	
9,702 genes had GO annotations. GO term enrichment anal‐
ysis was performed for all comparisons and time points to find 
significantly over‐ and under‐represented GO terms in the test 
set (DEGs, N > 10) with respect to the 9,702 genes with anno‐
tations as a reference set by using FatiGO package and a FDR 
<5%	(Al‐Shahrour,	Diaz‐Uriarte,	&	Dopazo,	2004)	implemented	in	
Blast2Go. Only the results with significant enrichment are pre‐
sented in the Results.
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TA B L E  2  RNA‐sequencing	statistics
Sample Clean reads Mapped readsa Mapping rate (%)




B1 24,597,756 23,968,026 97 19,918,942 81
B14 26,624,416 25,858,946 97 21,931,220 82
B17 23,999,196 22,651,278 94 17,802,808 74
B18 23,322,168 22,207,576 95 18,369,706 79
B2 23,555,686 22,880,536 97 19,149,848 81
B21 34,493,492 33,386,034 97 28,086,624 81
B22 24,617,926 23,694,502 96 19,953,830 81
B26 29,655,470 28,194,828 95 24,070,260 81
B29 30,939,654 29,544,114 95 24,867,174 80
B30 36,209,766 24,433,280 67 20,189,926 56
B33 45,625,028 28,638,828 63 23,836,070 52
B37 44,147,540 43,202,868 98 36,453,038 83
B38 27,820,672 24,703,250 89 21,374,226 77
B41 29,808,498 27,583,454 93 23,167,504 78
B42 42,889,884 41,943,030 98 35,365,472 82
B45 36,409,122 35,492,646 97 29,598,516 81
B46 35,596,746 34,842,904 98 29,326,366 82
B49 32,376,284 31,729,918 98 27,374,740 85
B5 23,006,502 22,439,386 98 19,046,868 83
B50 27,917,926 18,466,044 66 15,435,312 55
B53 40,673,650 39,796,846 98 34,006,420 84
B55 35,647,646 34,806,466 98 29,083,614 82
B6 29,826,016 23,599,508 79 19,401,850 65
B9 23,367,018 22,771,162 97 19,052,478 82
C11 27,657,994 26,788,868 97 22,619,380 82
C12 26,274,850 25,191,632 96 21,050,254 80
C15 26,534,292 24,556,092 93 20,509,984 77
C16 22,399,506 21,708,568 97 17,984,018 80
C20 26,934,682 26,215,608 97 21,817,700 81
C24 29,162,756 27,998,298 96 23,807,766 82
C27 22,016,854 21,160,562 96 17,886,560 81
C28 20,395,710 19,525,038 96 16,514,588 81
C3 33,093,148 32,073,232 97 26,728,794 81
C32 40,544,886 37,664,904 93 32,121,400 79
C35 40,764,376 39,594,362 97 33,079,892 81
C39 38,215,078 37,412,872 98 30,819,540 81
C4 26,290,796 25,462,524 97 21,168,056 81
C40 28,242,682 27,614,780 98 23,711,616 84
C43 35,737,580 34,957,488 98 29,299,620 82
C47 44,515,826 43,220,512 97 36,959,312 83
C48 34,970,550 34,112,530 98 28,931,718 83
C51 32,295,292 31,631,658 98 26,822,394 83
C52 39,323,204 38,495,180 98 32,743,424 83
C54 44,103,734 27,761,612 63 23,261,200 53
(Continues)
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3  | RESULTS
In this study, 48 transcriptomes of L. humile queens were se‐
quenced (Table 1). The mean number of clean reads per sample 
was 32 million of which on average 93% were mapped to the 
L. humile genome	and	79%	mapped	to	the	12,952	NCBI	annotated	
genes including protein‐coding, non‐coding, and pseudogenes 
(Table 2). The genome‐mapping rate was markedly lower (about 
65%)	for	four	samples:	B30,	B33,	B50,	and	C54	(Tables	1	and	2),	
which were excluded from further analyses. The removal affected 
the	following	data	points:	bacteria‐injected	social	queens	at	2	and	
12	hpi,	 bacteria‐injected	 isolated	queens	 at	4	hpi,	 and	Ringer‐in‐
jected	 social	 queens	 at	 4	hpi,	 which	 all	 involved	 two	 instead	 of	
three	biological	replicates.	In	the	PCA,	the	first	PC	explaining	37%	
of the variation in gene expression did not separate the samples 
according to the treatments, but the second PC explaining 9% of 
variance roughly separated the samples according to the type of 
injection	(Figure	2).
3.1 | Viral load of queens
Eight	RNA	viruses	were	identified	in	the	Trinity‐assembled	contigs	of	
reads that could not be mapped to the L. humile genome	(Viljakainen,	
Holmberg,	Abril,	&	Jurvansuu,	2018).	We	found	that	all	our	samples	
contained	RNA	viruses	at	different	loads.	The	type	of	injection	(bac‐
teria or Ringer) did not affect the virus loads per sample (two‐tailed 
t test: t	=	−1.36,	df = 22.49, p = 0.19), neither did the rearing condi‐
tion (two‐tailed t test: t = 0.05, df = 41.55, p = 0.95), suggesting an 
a priori viral load of the ants, which ranged from low to high levels. 
Importantly, we found that the gene expression profiles of the ants 
were affected by viral load (Figure 3), so that we controlled for viral 
load in the analysis of differential gene expression.
3.2 | Effect of social context
We first investigated the effect of social isolation per se by analyzing dif‐
ferentially	expressed	genes	in	Ringer‐injected	queens	that	were	either	
Sample Clean reads Mapped readsa Mapping rate (%)




C56 39,100,626 38,055,426 97 31,667,754 81
C57 31,438,698 30,558,738 97 26,153,756 83
C7 28,206,328 27,338,530 97 23,073,008 82
C8 21,029,550 20,324,252 97 17,309,046 82
Mean 31,507,855 29,297,056 93 24,643,825 79
aBoth reads of the read pair properly mapped. 
TA B L E  2   (Continued)
F I G U R E  2   Scatterplot of the first 
and second principal components from 
principal component analysis of variance 
stabilized gene expression counts showing 
that	the	type	of	injection	explains	9%	of	
variance in gene expression
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reared	alone	or	with	their	workers	(Figure	3,	Table	3,	and	Appendix:	
Table	A1).	The	total	number	of	DEGs	across	all	time	points	was	134	
with 82 up‐regulated and 52 down‐regulated genes. GO enrichment 
analysis showed enrichment of biological processes “single‐organism 
metabolic process,” “carbohydrate phosphorylation,” and “cellular glu‐
cose	homeostasis”	in	the	up‐regulated	genes	at	12	hpi	(Appendix:	Table	
A2).	We	hence	found	that	social	context	affected	queen	energy	me‐
tabolism, but had no effect on immune gene expression.
3.3 | Effect of bacterial infection depending on 
social context
We found that the effect of bacterial infection depended strongly 
on the social context the queens were reared at, even if the overall 
number	of	DEGs	across	all	time	points	induced	by	the	bacterial	injec‐
tion was similar across the social contexts, with 292 and 295 regu‐
lated genes in the presence and absence of workers, respectively 
(Figure	3,	Table	3,	Appendix:	Tables	A3	and	A4).	Some	of	the	genes	
were regulated at several time points, and taking this into account, 
the	number	of	unique	DEGs	was	272	in	the	socially	reared	and	268	
in the isolated queens with 110 of the genes shared between the 
social contexts. Despite these similar numbers, the direction of regu‐
lation differed greatly: In the presence of workers, queens typically 
showed	gene	up‐regulation	as	compared	to	their	Ringer	control	(65%	
of DEGs up‐regulated, χ2 = 25.33, df = 1, p = 4.83 × 10−7), whereas 
queens	reared	alone	showed	mostly	down‐regulation	(63%	of	DEGs	
down‐regulated; χ2	=	21.16,	df = 1, p = 4.23 × 10−6), and only 22 of 
the up‐regulated genes and 27 of the down‐regulated genes were 
shared between the social treatments. Contrary to this overall dif‐
ference in up‐regulation versus down‐regulation, both social and 




The	majority	 of	 the	DEGs	were	 not	 directly	 related	 to	 immune	
response, the core immune genes representing only 5% and 9% of 
the regulated genes in social and isolated queens, respectively. To get 
insight on the affected biological processes and molecular functions, 
GO enrichment analysis was carried out for treatment contrasts with 








isolated queens and viral load taken into account as a cofactor
TA B L E  3   Differentially expressed genes in all treatment 
contrasts and time points
Contrast Hpi Up Down DEG total
BS versus CS 2 7 6 13
4 136 62 198
8 35 33 68
12 11 2 13
Total 189 103 292
BI versus CI 2 18 95 113
4 16 42 58
8 9 5 14
12 65 45 110
Total 108 187 295
BI versus BS 2 1 0 1
4 0 7 7
8 0 1 1
12 9 2 11
Total 10 10 20
CI versus CS 2 3 1 4
4 1 0 1
8 26 28 54
12 52 23 75
Total 82 52 134
B:	bacteria;	C:	control;	Hpi:	Hours	post‐injection;	I:	isolated;	S:	social.























































































































































































































































































































































































































































































































































































































































































































































































































































































     |  11039VILJAKAINEN Et AL.
at least 10 DEGs. The up‐regulated genes of social queens at 4 hpi 
showed enrichment of proteolysis and serine‐type endopeptidase 
inhibitor	activity	(Appendix:	Table	A2).	In	the	isolated	queens,	down‐
regulated genes at 2 hpi showed enrichment of proteolysis, molyb‐
dopterin cofactor biosynthetic process, and serine protease inhibitor 
activity	(Appendix:	Table	A2).	The	genes	categorized	as	being	involved	
in proteolysis and having serine protease inhibitor activity were 
largely the same genes as in the social queens. Oxidation‐reduction 
process was enriched in the down‐regulated genes of isolated queens 
at	12	hpi	including	gene	encoding	for	phenoloxidase	(LOC105668871)	
and several cytochrome P450 protein‐coding genes.
3.4 | Activation of Toll signaling pathway
The expression of immune genes indicated activation of the signaling 
pathway Toll (Table 4). In social queens, five Toll pathway genes were 
up‐regulated. These included beta‐1,3‐glucan‐binding protein (BGBP, 
LOC105673881),	based	on	BLASTP	search	 similar	 to	Drosophila mi‐
crobial	 recognition	 protein	 GNBP1	 (GenBank	 Accession	 number	
NP_524142,	34%	 identity,	 92%	coverage)	 involved	 in	 recognition	of	
gram‐positive bacteria (Pili‐Floury et al., 2004). Up‐regulated were 
also two genes encoding serine proteases: limulus clotting factor C‐
like	 (LOC105673362)	 similar	 to	Drosophila modular serine protease, 
modSP	(NP_536776,	27%	identity,	97%	coverage),	and	serine protease 
snake‐like	 (LOC105675725)	 similar	 to	Drosophila snake	 (NP_524338,	
39%	identity,	56%	coverage).	Both	modSP	and	snake	are	involved	in	
activation of the Toll receptor by transmitting microbial recognition 




identity, 70% coverage and 30% identity, 48% coverage, respectively).
In the isolated queens, seven Toll pathway genes were up‐regu‐
lated and two down‐regulated (Table 4). Three genes encoding for 
serine proteases, all involved in the activation of the Toll pathway in a 
similar way described above for modSP and snake, were up‐regulated: 
two limulus clotting factor C‐like	(LOC105673362	and	LOC105673363)	
similar to Drosophila	modSP	(NP_536776,	27%	identity,	97%	cover‐
age and 31% identity, 94% coverage, respectively) and additionally, 
serine protease gd‐like (LOC105671866)	similar	to	gastrulation‐defec‐
tive in Drosophila (NP_001303552,	29%	identity,	84%	coverage)	that	
presumably activates serine protease snake (Rose et al., 2003). One 
gene	encoding	Toll‐like	protein	(LOC105678784)	similar	to	Drosophila 
Toll	(NP_524518,	36%	identity,	90%	coverage),	which	is	a	transmem‐
brane receptor, was up‐regulated, and two Toll‐like protein‐coding 
genes	were	down‐regulated	 (LOC105678817	and	LOC105678912).	
Two genes downstream of Toll receptor were up‐regulated, cactus‐1a 
(LOC105678482)	 and	 cactus‐1b	 (LOC105678483),	 both	 similar	 to	
Drosophila cactus	(NP_476943,	43%	identity,	50%	coverage	and	38%	
identity,	76%	coverage,	respectively)	which	is	an	inhibitor	of	NF‐κB 
transcription factor Dorsal that positively regulates the transcription 
of	 antimicrobial	 peptides	 (AMPs;	 Ferrandon	 et	 al.,	 2007).	Notably,	
our analysis only revealed two Toll pathway genes overlapping 
between the social and isolated queens, limulus clotting factor C‐like 
(LOC105673362)	and	protein Toll‐like	(LOC105678817),	of	which	the	
latter was significantly up‐regulated in the social queens while down‐
regulated in the isolated queens.
3.5 | Activation of Imd signaling pathway
Genes along the Imd pathway were not as widely represented among 
the DEGs as the Toll pathway genes (Table 4). Down‐regulated in 
both social and isolated queens was a gene encoding for peptidogly‐
can‐recognition	protein	SC2	(PGRP‐SC2,	LOC105675773),	which	is	a	
negative	regulator	of	the	Imd	pathway	(Bischoff	et	al.,	2006).	In	addi‐
tion, isolated queens showed up‐regulation of a gene encoding for the 
NF‐κB‐like	transcription	factor	Relish	 (LOC105668729)	 (Ferrandon	
et	al.,	2007)	and	for	uncharacterized	protein	(LOC105678813)	simi‐
lar to Drosophila poor	Imd	response	upon	knock‐in	(NP_001286686,	
39% identity, 24% coverage), which, again, is a negative regulator of 
the Imd pathway (Kleino et al., 2008).
3.6 | Expression of antimicrobial peptides
The Toll and Imd signaling cascades culminate in the expression of 
AMPs	(Ferrandon	et	al.,	2007),	which	are	immune	effectors	attacking	
fungal	and	bacterial	pathogens	in	the	host.	In	social	queens,	one	AMP	
encoding gene, hymenoptaecin	 (LOC105670591)	 (Casteels,	 Ampe,	
Jacobs,	&	Tempst,	1993),	was	up‐regulated	at	12	hpi,	and	two	AMP	
genes were down‐regulated at 4 hpi: defensin‐2 (LOC105675717)	
and chymotrypsin inhibitor‐like	 (LOC105675436)	 similar	 (41%	 iden‐
tity,	71%	coverage)	to	ixodidin	(P83516),	which	has	been	character‐
ized in the Cattle tick Rhipicephalus microplus (Fogaça	et	al.,	2006).
3.7 | Melanization
Melanization—an active mechanism to encapsulate pathogens 
within the host—was induced in both social and isolated queens 
indicated by a number of up‐regulated genes (Table 4), for ex‐
ample, venom protease‐like	 (LOC105677585)	 similar	 to	 venom	
serine	 protease	 (B5U2W0,	 50%	 identity,	 96%	 coverage)	 from	
Bombus ignitus, which is shown to activate the phenoloxidase 
cascade (Choo et al., 2010). Once activated, phenoloxidase cata‐
lyzes the production of quinones, which are polymerized to mi‐
crobicidal melanin (De Gregorio et al., 2002). Up‐regulated were 
also N‐(5‐amino‐5‐carboxypentanoyl)‐l‐cysteinyl‐d‐valine synthase 
(LOC105676303)	 similar	 to	 ebony from Drosophila (NP_524431,	
47% identity, 98% coverage) and aromatic‐l‐amino acid decarboxy‐
lase (LOC105674352),	 similar	 to	 Drosophila dopa decarboxylase 
(NP_724164,	74%	 identity,	90%	coverage),	 both	 involved	 in	mel‐
anization	(Riedel,	Vorkel,	&	Eaton,	2011).
3.8 | Phagocytosis
Three genes involved in phagocytosis were down‐regulated 
(Table 4). These involved a gene encoding for scavenger receptor 
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class	B	member	1‐like	(LOC105678691)	and	protein	croquemort‐like	
(LOC105671541),	 both	 similar	 to	Drosophila croquemort	 (Q27367,	
28% identity, 75% coverage and 37% identity, 90% coverage, re‐
spectively) required in the uptake of bacteria by phagocytes (Guillou, 
Troha,	Wang,	Franc,	&	Buchon,	2016),	and	fibrillin‐1	(LOC105675281)	
similar to Drosophila eater	(NP_651533,	37%	identity,	49%	coverage)	
that is also a phagocytic receptor promoting engulfment of bacteria 
(Kocks et al., 2005). Up‐regulated was a gene encoding for alpha‐2‐
macroglobulin‐like	protein	1	 (LOC105677178)	similar	 to	Drosophila 
TepII	 (NP_723300,	 34%	 identity,	 37%	 coverage)	 that	 recognizes	
surface structures of bacteria leading to phagocytosis (Shokal, 
Kopydlowski, & Eleftherianos, 2017). Here, only the gene encoding 
for	scavenger	receptor	class	B	member	1‐like	(LOC105678691)	was	
regulated in both social and isolated queens.
3.9 | Interaction effect of social isolation and 
bacterial injection
An	interaction	analysis	of	social	isolation	and	bacterial	injection	at	all	
the four time points showed regulation of 20 genes across all time 
points	in	the	bacteria‐injected	isolated	queens	(Tables	3	and	5).	These	
included down‐regulation at 4 hpi of the Toll receptor activator‐gene 
spätzle	(LOC105678357),	up‐regulation	at	12	hpi	of	the	Imd	pathway	
signaling gene imd	 (LOC105672003)	 and	 down‐regulation,	 also	 at	
12 hpi, of hemocyte protein–glutamine gamma‐glutamyl transferase‐
like	 (LOC105670674)	 similar	 to	 transglutaminase	 (NP_609174,	 37%	
identity, 90% coverage) in Drosophila that inhibits the Imd pathway 
transcription factor Relish (Maki, Shibata, & Kawabata, 2017).
Hence, in both presence and absence of workers, all important 
immune defense pathways were triggered in the queens, with the 
highest number in the Toll pathway.
4  | DISCUSSION
In this study, we tested how the presence or absence of workers 
affects ant queen immune response after bacterial infection. When 
testing for the effect of our experimentally induced bacterial infec‐
tions, we found that existing viral load had an effect on differential 
gene expression analyses and that virus presence and load should be 
taken into account in these types of analysis, as previously reported 
(Gerth & Hurst, 2017). To further control for the effect of social 
worker presence or absence per se in the absence of an infection, we 
first	analyzed	differential	gene	expression	between	Ringer‐injected	
TA B L E  5  Differentially	expressed	genes	in	bacteria‐injected	isolated	queens	in	interaction	analysis	of	social	environment	and	bacterial	
treatment	with	false	discovery	rate	<10%.	T2,	T4,	T8,	and	T12	indicate	the	post‐injection	time	points
Time point Locus Description LFC p‐Value Adjusted p‐value
T2 LOC105672931 Uncharacterized protein 
LOC105672931
1.41 5.31E−06 6.69E−02
T4 LOC105678357 Protein	spätzle −1.40 2.61E−10 3.28E−06
LOC105668988 Uncharacterized	LOC105668988 −7.82 5.81E−08 3.64E−04
LOC105667488 Uncharacterized	LOC105667488 −2.50 1.71E−05 6.36E−02
LOC105668757 Non‐coding	RNA −1.74 2.03E−05 6.36E−02
LOC105668733 Lambda‐crystallin	homolog −0.55 3.13E−05 6.55E−02




T8 LOC105675386 Sodium‐coupled monocarboxylate 
transporter 1
−0.65 3.45E−06 4.35E−02
T12 LOC105677280 Uncharacterized	LOC105677280 2.01 8.53E−11 9.68E−07
LOC105674672 Cholesterol	desaturase	daf‐36 1.49 6.29E−08 3.57E−04
LOC105675029 Uncharacterized	LOC105675029 −0.83 1.20E−06 4.54E−03
LOC105677088 Cytochrome P450 9e2‐like 0.99 2.24E−06 6.36E−03
LOC105670674 Hemocyte protein–glutamine 
gamma‐glutamyl transferase‐like
−0.59 9.36E−06 1.77E−02
LOC105672003 Uncharacterized (imd) 0.81 9.08E−06 1.77E−02
LOC105673930 MLX‐interacting	protein 0.47 2.47E−05 4.01E−02
LOC105669664 Uncharacterized	LOC105669664 1.17 8.56E−05 9.87E−02
LOC105671661 Inositol polyphosphate multikinase 0.47 9.57E−05 9.87E−02
LOC105675400 Uncharacterized	LOC105675400 0.50 8.01E−05 9.87E−02
LOC105676429 Protein embryonic gonad‐like 0.73 9.19E−05 9.87E−02
LFC:	log2 fold change.
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queens reared in the social environment or alone. Despite our sam‐
ple size being large enough to detect significant effects of rearing on 
queen metabolism, we could not detect any general effect on queen 
immune gene expression.
We then tested whether worker presence or absence interfered 
with the queens’ individual immune response to bacterial infection 
over	the	course	of	infection.	Overall,	we	found	that	injection	of	bac‐
teria, over the four time points studied, affected the expression of 
similar numbers of genes in both social and isolated queens but in‐
terestingly,	the	social	queens	up‐regulated	the	majority	of	the	genes,	
whereas in the isolated queens, down‐regulation was prevailing. This 
general down‐regulation might be a consequence of social isolation, 
which has been shown to affect life‐history traits by reducing lon‐
gevity in workers of the ant Camponotus fellah (Boulay et al., 1999; 
Koto et al., 2015), yet did not compromise the innate immune re‐
sponse of bumblebees after pathogen challenge (Richter, Helbing, 
Erler,	&	Lattorff,	2012).	 In	 the	group‐living	earwig	Forficula auricu‐
laria, rearing individuals alone also lead to a transiently increased 
susceptibility after pathogen exposure shortly after isolation, yet an 
indistinguishable survival of individuals living isolated or in groups 
for	longer	periods	(Kohlmeier	et	al.,	2016),	hence	the	effects	of	social	
isolation may be plastic, both varying over time and across species.
The isolated queens regulated slightly, but not significantly, 
higher number of the core immune genes than social queens (23 vs. 
14, χ2 = 3.38, df = 1, p = 0.07) and the immune gene expression in 
the isolated queens did not show the overall pattern of down‐reg‐
ulation	observed	 in	all	of	 their	DEGs:	65%	of	 immune	genes	were	
up‐regulated as opposed to 37% of all DEGs (χ2 = 8.11, df = 1, 
p = 0.004). Therefore, even though gene expression in the isolated 
queens showed a trend of down‐regulation, the activation of cellular 
and humoral immune cascades was comparable to the social queens.
An	 interesting	observation	was	 two	enriched	GO	 terms,	 ser‐
ine protease inhibitor activity and proteolysis, both categories 
including approximately 20 genes, which were up‐regulated at 
4	hpi	 in	 the	 bacteria‐injected	 social	 queens	 and	 down‐regulated	
at	2	hpi	in	the	bacteria‐injected	isolated	queens.	All	except	one	of	
the genes in the serine protease inhibitor‐category were long non‐
coding	RNAs	(lncRNA)	which	Blast2Go	annotation	found	to	con‐
tain a protease inhibitor domain suggesting they might regulate 
serine protease inhibitors (serpins). In insects, serpins are known 
to be involved in the regulation of immune signaling cascades, 
phagocytosis, and digestion (Gubb, Sanz‐Parra, Barcena, Troxler, 
&	Fullaondo,	2010),	and	the	expression	of	serpin‐related	lncRNAs	
could be involved in the fine‐tuning of various arms of immune 
response. It is striking that the gene expression patterns of these 
genes showed opposite directions in the two rearing conditions, 
highlighting the strong effect of social environment on the general 
response	to	bacterial	injection.
As	a	conclusion,	this	study	shows	that	ant	queens	were	equally	
able to activate innate immune signaling cascades after bacterial 
injection	when	kept	 together	with	workers	or	when	 reared	 alone.	
This	reveals	that	pathogen‐injected	queens	raise	an	induced	immune	
response even in the presence of rearing workers, yet that worker 
presence interferes with which exact set of genes is regulated. 
Hence, we could show that individual queen responses are not com‐
promised, but modulated by their social context.
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TA B L E  A 1  Differentially	expressed	genes	in	Ringer‐injected	isolated	queens	with	false	discovery	rate	<10%.	T2,	T4,	T8,	and	T12	indicate	
the	post‐injection	time	points



















LOC105670097 Spidroin‐1	(LOC105670097) 6.86 1.91E−06 1.34E−03







LOC105678672 1.82 2.49E−05 1.13E−02
LOC105671207 A	disintegrin	and	metalloproteinase	with	







thrombospondin motifs 17‐like 
(LOC105679161)
1.61 2.17E−04 6.99E−02
LOC105678664 1.57 2.57E−06 1.61E−03












LOC105679050 Transcription termination factor 2‐like 
(LOC105679050)
1.12 2.35E−05 1.12E−02
LOC105671872 Vitellogenin‐2‐like	(LOC105671872) 0.98 1.88E−07 2.35E−04
LOC105675620 Aminopeptidase	N‐like	(LOC105675620) 0.96 4.00E−04 8.24E−02
LOC105670430 Aminopeptidase	N‐like	(LOC105670430) 0.90 3.45E−04 7.94E−02






LOC105678648 Protein	toll‐like	(LOC105678648) 0.84 2.11E−05 1.06E−02
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TA B L E  A 1   (Continued)
Time point Locus Description LFC p‐Value Adjusted p‐value









LOC105671841 Pleckstrin homology domain‐containing 
family	M	member	2	(LOC105671841)
0.66 2.85E−04 7.60E−02














LOC105674352 Aromatic‐l‐amino acid decarboxylase 
(LOC105674352)
−0.95 4.96E−04 9.37E−02
LOC105677051 Protein	Malvolio	(LOC105677051) −0.95 4.00E−04 8.24E−02
LOC105670059 Probable serine/threonine‐protein kinase 
kinX	(LOC105670059)
−0.96 5.60E−05 2.44E−02
LOC105672810 Protein	yellow	(LOC105672810) −1.02 7.95E−05 3.06E−02









LOC105674532 ETS homologous factor‐like 
(LOC105674532)
−1.10 3.64E−08 9.11E−05













LOC105676197 5‐aminolevulinate synthase −1.34 5.32E−08 1.06E−04






LOC105670071 Glucosylceramidase‐like	(LOC105670071) −1.45 4.18E−04 8.24E−02
LOC105679194 Muscle segmentation homeobox‐like 
(LOC105679194)
−1.82 2.81E−12 1.40E−08
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TA B L E  A 1   (Continued)
Time point Locus Description LFC p‐Value Adjusted p‐value


















LOC105672897 3.37 1.56E−14 3.29E−11







LOC105672083 Cytochrome P450 4c21‐like 
(LOC105672083)
2.71 1.01E−04 2.33E−02

















LOC105668386 Trifunctional purine biosynthetic protein 
adenosine‐3	(LOC105668386)
2.24 9.29E−05 2.27E−02
LOC105671469 d‐arabinitol dehydrogenase 1‐like 
(LOC105671469)
2.22 1.99E−04 3.56E−02
LOC105673823 Glucose	dehydrogenase	[FAD 2.16 4.39E−06 2.31E−03






LOC105669805 Facilitated trehalose transporter Tret1‐2 
homolog	(LOC105669805)
2.08 5.43E−04 8.40E−02
LOC105667792 Synaptotagmin‐6	(LOC105667792) 2.00 1.08E−04 2.33E−02
LOC105676997 Patatin‐like phospholipase domain‐con‐
taining	protein	3	(LOC105676997)
1.97 3.37E−09 3.22E−06
LOC105667804 Uncharacterized family 31 glucosidase 
KIAA1161	(LOC105667804)
1.92 5.44E−07 3.81E−04
LOC105674420 3'(2') 1.89 2.22E−05 7.30E−03
LOC105670888 Hexokinase	type	2‐like	(LOC105670888) 1.88 2.23E−10 2.61E−07
(Continues)
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TA B L E  A 1   (Continued)
Time point Locus Description LFC p‐Value Adjusted p‐value
LOC105678328 T‐lymphocyte activation antigen 
CD86‐like	(LOC105678328)
1.85 6.15E−05 1.59E−02
LOC105674418 Beta‐1 1.78 8.76E−07 5.43E−04
LOC105668703 Membrane metalloendopeptidase‐like 1 
(LOC105668703)
1.71 1.61E−05 5.70E−03







LOC105676329 Insulin‐like growth factor‐binding protein 
complex acid labile subunit 
(LOC105676329)
1.53 5.78E−06 2.77E−03
LOC105674747 Cytosolic purine 5'‐nucleotidase 
(LOC105674747)
1.51 2.64E−06 1.46E−03
LOC105680118 Cysteine proteinase 1‐like 
(LOC105680118)
1.49 5.94E−04 8.74E−02
LOC105675420 Protein	yellow‐like	(LOC105675420) 1.48 5.08E−05 1.37E−02
LOC105669199 6‐phosphofructo‐2‐kinase/fructose‐2 1.43 1.35E−05 5.09E−03
LOC105674352 Aromatic‐l‐amino acid decarboxylase 
(LOC105674352)
1.37 1.03E−05 4.32E−03
LOC105667680 Probable hydroxyacid‐oxoacid 
transhydrogenase
1.37 1.59E−04 3.16E−02
LOC105675723 Serine protease snake‐like 
(LOC105675723)
1.36 1.62E−05 5.70E−03
LOC105668704 Organic cation transporter protein 
(LOC105668704)
1.36 4.04E−05 1.15E−02
LOC105674248 Branched‐chain‐amino acid 
aminotransferase
1.35 2.78E−05 8.59E−03








LOC105677283 Alpha‐aminoadipic	semialdehyde	synthase 1.14 4.72E−04 7.52E−02
LOC105671238 Exosome	component	10	(LOC105671238) 1.14 6.13E−04 8.85E−02
LOC105675407 Inhibin	beta	E	chain	(LOC105675407) 1.10 3.55E−04 5.92E−02
LOC105667297 Protein	LTV1	homolog	(LOC105667297) 1.08 4.42E−04 7.27E−02
LOC105671942 Hexokinase‐2‐like	(LOC105671942) 1.08 8.18E−05 2.05E−02






LOC105675717 Defensing‐2	(LOC105675717) −1.39 4.68E−04 7.52E−02
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Time point Locus Description LFC p‐Value Adjusted p‐value
LOC105677041 Cytochrome P450 4C1‐like 
(LOC105677041)
−1.65 6.99E−04 9.94E−02
LOC105671746 Probable cytochrome P450 304a1 
(LOC105671746)
−1.67 6.10E−08 5.35E−05




















LOC105670118 Uncharacterized methyltransferase‐like 
protein	SPBC21C3.07c	(LOC105670118)
−2.07 5.80E−04 8.72E−02




















TA B L E  A 1   (Continued)
TA B L E  A 2   Results of gene ontology enrichment analysis
GO_name GO_Category FDR p‐Value
Enrichment of up‐regulated genes in bacteria‐injected queens in social environment at 4 hpi
Serine‐type endopeptidase inhibitor 
activity
MOLECULAR_FUNCTION 1.13E−33 2.00E−37
Endopeptidase inhibitor activity MOLECULAR_FUNCTION 6.65E−33 3.51E−36
Endopeptidase regulator activity MOLECULAR_FUNCTION 6.65E−33 3.51E−36
Peptidase inhibitor activity MOLECULAR_FUNCTION 8.42E−32 7.41E−35
Peptidase regulator activity MOLECULAR_FUNCTION 8.42E−32 7.41E−35
Enzyme inhibitor activity MOLECULAR_FUNCTION 8.24E−30 8.70E−33
Enzyme regulator activity MOLECULAR_FUNCTION 1.89E−20 2.33E−23
Molecular function regulator MOLECULAR_FUNCTION 4.10E−17 5.77E−20
Metallopeptidase activity MOLECULAR_FUNCTION 1.07E−10 1.69E−13
(Continues)
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GO_name GO_Category FDR p‐Value
Peptidase activity, acting on l‐amino acid 
peptides
MOLECULAR_FUNCTION 1.80E−06 3.16E−09
Peptidase activity MOLECULAR_FUNCTION 3.77E−06 7.30E−09
Proteolysis BIOLOGICAL_PROCESS 1.21E−04 2.54E−07
Metalloendopeptidase activity MOLECULAR_FUNCTION 0.0088 2.01E−05
Transition metal ion binding MOLECULAR_FUNCTION 0.0466 1.15E−04
Enrichment of down‐regulated genes in bacteria‐injected isolated queens at 2 hpi
Serine‐type endopeptidase inhibitor 
activity
MOLECULAR_FUNCTION 9.33E−24 1.64E−27
Endopeptidase inhibitor activity MOLECULAR_FUNCTION 2.11E−23 1.12E−26
Endopeptidase regulator activity MOLECULAR_FUNCTION 2.11E−23 1.12E−26
Peptidase inhibitor activity MOLECULAR_FUNCTION 9.97E−23 8.77E−26
Peptidase regulator activity MOLECULAR_FUNCTION 9.97E−23 8.77E−26
Enzyme inhibitor activity MOLECULAR_FUNCTION 2.17E−21 2.29E−24
Enzyme regulator activity MOLECULAR_FUNCTION 8.09E−15 9.96E−18
Metallopeptidase activity MOLECULAR_FUNCTION 5.74E−13 8.08E−16
Molecular function regulator MOLECULAR_FUNCTION 1.73E−12 2.74E−15
Peptidase activity, acting on l‐amino acid 
peptides
MOLECULAR_FUNCTION 2.26E−07 3.98E−10
Peptidase activity MOLECULAR_FUNCTION 4.47E−07 8.65E−10
Proteolysis BIOLOGICAL_PROCESS 2.95E−06 6.23E−09
Metalloendopeptidase activity MOLECULAR_FUNCTION 3.96E−05 9.05E−08
Zinc	ion	binding MOLECULAR_FUNCTION 5.47E−04 1.35E−06
Hydrolase activity MOLECULAR_FUNCTION 0.0016 4.33E−06
Transition metal ion binding MOLECULAR_FUNCTION 0.0032 8.95E−06
Molybdopterin cofactor metabolic 
process
BIOLOGICAL_PROCESS 0.0403 1.35E−04
Prosthetic group metabolic process BIOLOGICAL_PROCESS 0.0403 1.35E−04
Molybdopterin cofactor biosynthetic 
process
BIOLOGICAL_PROCESS 0.0403 1.35E−04
Endopeptidase activity MOLECULAR_FUNCTION 0.0479 1.77E−04
Exopeptidase activity MOLECULAR_FUNCTION 0.0479 1.77E−04
Enrichment of down‐regulated genes in bacteria‐injected isolated queens at 12 hpi
Oxidoreductase activity MOLECULAR_FUNCTION 0.0216 7.60E−06
Oxidation‐reduction process BIOLOGICAL_PROCESS 0.0216 7.49E−06
Enrichment of up‐regulated genes in Ringer‐injected isolated queens at 12 hpi
Single‐organism metabolic process BIOLOGICAL_PROCESS 0.0024 4.28E−07
Carbohydrate kinase activity MOLECULAR_FUNCTION 0.0120 6.36E−06
Carbohydrate phosphorylation BIOLOGICAL_PROCESS 0.0120 4.47E−06
Cellular glucose homeostasis BIOLOGICAL_PROCESS 0.0310 4.37E−05
Glucose binding MOLECULAR_FUNCTION 0.0310 4.37E−05
Carbohydrate homeostasis BIOLOGICAL_PROCESS 0.0310 4.37E−05
Hexokinase activity MOLECULAR_FUNCTION 0.0310 4.37E−05
Glucose homeostasis BIOLOGICAL_PROCESS 0.0310 4.37E−05
TA B L E  A 2   (Continued)
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TA B L E  A 3  Differentially	expressed	genes	in	bacteria‐injected	social	queens	with	false	discovery	rate	<10%.	T2,	T4,	T8,	and	T12	indicate	
the	post‐injection	time	points
Time 



















LOC105676587 Trypsin‐like	(LOC105676587) 1.73 9.33E−05 9.17E−02
LOC105674885 Purine nucleoside phosphorylase‐like 
(LOC105674885)
−1.99 1.41E−04 9.84E−02





















with thrombospondin motifs 4‐like 
(LOC105679565)
7.51 1.67E−03 9.52E−02
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TA B L E  A 3   (Continued)
Time 
point Locus Description LFC p‐Value Adjusted p‐value
LOC105671207 A	disintegrin	and	metalloproteinase	
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TA B L E  A 3   (Continued)
Time 
point Locus Description LFC p‐Value Adjusted p‐value
LOC105670598 A	disintegrin	and	metalloproteinase	






















LOC105678344 Gephyrin‐like	(LOC105678344) 2.77 3.07E−05 3.70E−03











































LOC105668795 Flavin‐containing monooxygenase 
FMO	GS‐OX‐like	3	(LOC105668795)
2.30 7.32E−09 3.04E−06
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TA B L E  A 3   (Continued)
Time 














































































11054  |     VILJAKAINEN Et AL.
TA B L E  A 3   (Continued)
Time 














































LOC105670214 Tissue factor pathway inhibitor‐like 
(LOC105670214)
1.60 8.25E−05 8.80E−03
LOC105673951 Chymotrypsin‐1‐like	(LOC105673951) 1.59 6.92E−07 1.43E−04
LOC105668779 Troponin C 1.55 8.95E−06 1.30E−03
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LOC105675133 Mitochondrial uncoupling protein 
2‐like	(LOC105675133)
1.42 2.67E−07 6.96E−05
LOC105672982 Chromosome‐associated kinesin KIF4 
(LOC105672982)
1.39 7.11E−05 7.73E−03
LOC105677706 Bipolar kinesin KRP‐130‐like 
(LOC105677706)
1.37 6.99E−04 4.69E−02












LOC105671386 Organic cation transporter 1‐like 
(LOC105671386)
1.25 9.68E−04 6.03E−02
LOC105675373 Cyclin‐dependent kinase 4 
(LOC105675373)
1.24 2.52E−05 3.25E−03
LOC105669176 Organic cation transporter protein‐
like	(LOC105669176)
1.22 1.69E−04 1.59E−02




















LOC105668364 Mesencephalic astrocyte‐derived 
neurotrophic factor homolog 
(LOC105668364)
0.91 1.74E−03 9.83E−02
LOC105668947 Endoplasmin	(LOC105668947) 0.83 1.69E−03 9.60E−02
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LOC105670714 Alpha‐amylase	A	(LOC105670714) −1.01 3.79E−04 2.88E−02







LOC105676883 Serine hydroxymethyltransferase −1.08 4.27E−04 3.08E−02




LOC105671942 Hexokinase‐2‐like	(LOC105671942) −1.12 9.69E−04 6.03E−02
LOC105672608 Facilitated trehalose transporter 
Tret1‐like	(LOC105672608)
−1.14 7.47E−04 4.92E−02
LOC105678761 Serine protease inhibitor 3/4‐like 
(LOC105678761)
−1.17 4.04E−04 2.98E−02
LOC105675773 Peptidoglycan‐recognition protein 
SC2‐like	(LOC105675773)
−1.20 9.78E−06 1.40E−03
LOC105669805 Facilitated trehalose transporter 
Tret1‐2	homolog	(LOC105669805)
−1.22 4.34E−05 4.97E−03
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LOC105674346 Neural‐cadherin	(LOC105674346) −1.49 3.92E−08 1.29E−05
LOC105671703 Facilitated trehalose transporter 
Tret1‐like	(LOC105671703)
−1.52 1.39E−03 8.15E−02




LOC105679180 Solute carrier family 2 −1.59 3.18E−07 7.68E−05
LOC105671469 d‐arabinitol dehydrogenase 1‐like 
(LOC105671469)
−1.66 1.69E−09 8.22E−07
LOC105675436 Chymotrypsin inhibitor‐like 
(LOC105675436)
−1.69 1.42E−10 9.16E−08
LOC105669509 Arylsulfatase	B‐like	(LOC105669509) −1.71 4.52E−06 7.23E−04
LOC105669158 Sorbitol dehydrogenase‐like 
(LOC105669158)
−1.71 8.01E−09 3.21E−06
LOC105675717 Defensing‐2	(LOC105675717) −1.80 1.05E−08 3.93E−06



























LOC105675643 Prismalin‐14‐like	(LOC105675643) −2.29 2.95E−05 3.59E−03
LOC105678258 Facilitated trehalose transporter 
Tret1‐like	(LOC105678258)
−2.35 1.24E−03 7.41E−02
LOC105668871 Phenoloxidase 2‐like 
(LOC105668871)
−2.36 8.57E−17 1.37E−13
LOC105676062 Protein	henna	(LOC105676062) −2.37 3.44E−08 1.17E−05






LOC105667386 Hexamerin‐like	(LOC105667386) −2.63 4.83E−12 4.51E−09
LOC105675433 Dynein beta chain, ciliary 
(LOC105675433)
−2.97 1.07E−07 3.08E−05
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LOC105672439 Alpha‐sarcoglycan	(LOC105672439) 1.37 3.77E−05 1.29E−02
LOC105671866 Serine protease gd‐like 
(LOC105671866)
1.29 2.23E−07 1.48E−04






LOC105669027 Putative	nuclease	HARBI1	(pseudo) 1.19 3.03E−04 6.71E−02
LOC105673881 Beta‐1,3‐glucan‐binding protein‐like 
(LOC105673881)
1.18 1.43E−05 5.70E−03
















LOC105680007 Protein	toll	(LOC105680007) 0.98 3.45E−04 7.12E−02
LOC105672359 Thiamine transporter 2‐like 
(LOC105672359)
0.97 3.29E−04 6.90E−02







     |  11059VILJAKAINEN Et AL.
TA B L E  A 3   (Continued)
Time 








LOC105673707 Kinesin‐like protein unc‐104 
(LOC105673707)
0.84 1.10E−04 2.99E−02












LOC105671406 Putative phosphatidate phosphatase 
(LOC105671406)
0.72 4.17E−04 8.09E−02
LOC105676136 Guanine nucleotide‐binding protein 
G(i)	subunit	alpha	(LOC105676136)
0.69 1.99E−05 7.47E−03
LOC105671687 Plastin‐2	(LOC105671687) 0.66 5.64E−04 9.93E−02
LOC105673509 Ankyrin	repeat	and	BTB/POZ	












LOC105671942 Hexokinase‐2‐like	(LOC105671942) −0.71 4.58E−04 8.56E−02
LOC105669509 Arylsulfatase	B‐like	(LOC105669509) −0.74 2.60E−04 5.98E−02




LOC105678768 Lipoyltransferase	1 −0.81 1.31E−04 3.40E−02







LOC105674437 Aquaporin‐like	(LOC105674437) −1.01 8.98E−07 5.37E−04













LOC105672628 Esterase	FE4‐like	(LOC105672628) −1.13 4.28E−08 3.42E−05
(Continues)
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LOC105679194 Muscle segmentation homeobox‐like 
(LOC105679194)
−1.54 2.47E−06 1.29E−03
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LOC105677207 Gamma‐glutamyl transpeptidase 
1‐like	(LOC105677207)
2.04 5.11E−05 5.28E−02
LOC105677194 Glucose dehydrogenase 1.82 2.74E−05 3.09E−02











TA B L E  A 3   (Continued)
TA B L E  A 4  Differentially	expressed	genes	in	bacteria‐injected	isolated	queens	with	false	discovery	rate	<10%.	T2,	T4,	T8,	and	T12	
indicate	the	post‐injection	time	points
Time point Locus Description LFC p‐Value
Adjusted 
p‐value
T2 LOC105672684 Protein	hairy	(LOC105672684) 1.75 3.31E−06 1.93E−03
LOC105672434 Uncharacterized	LOC105672434	(LOC105672434) 1.53 2.39E−11 5.13E−08
LOC105670707 Uncharacterized transmembrane protein DDB_
G0289901‐like	(LOC105670707)
1.48 2.33E−07 2.27E−04
LOC105675132 Uncharacterized	LOC105675132	(LOC105675132) 1.45 3.35E−04 4.66E−02
LOC105673362 Limulus	clotting	factor	C‐like	(LOC105673362) 1.45 4.68E−07 4.18E−04









LOC105676540 Uncharacterized	LOC105676540	(LOC105676540) 1.06 1.79E−05 6.19E−03
LOC105676242 Uncharacterized	LOC105676242	(LOC105676242) 0.96 9.84E−08 1.17E−04
LOC105668293 Chymotrypsin‐1‐like	(LOC105668293) 0.94 7.93E−06 3.81E−03
LOC105672325 Calcium‐binding mitochondrial carrier protein 
SCaMC‐2‐like	(LOC105672325)
0.90 6.63E−04 7.04E−02
LOC105671678 Collagen	alpha‐2(I)	chain‐like	(LOC105671678) 0.89 5.94E−05 1.35E−02
LOC105679973 Fatty acid binding protein 1‐B.1‐like 
(LOC105679973)
0.82 1.46E−04 2.56E−02
LOC105677611 Uncharacterized	LOC105677611	(LOC105677611) 0.76 1.73E−04 2.86E−02







LOC105677684 E3 ubiquitin‐protein ligase TRIM71 
(LOC105677684)
−0.72 1.01E−04 2.03E−02
LOC105678648 Protein	toll‐like	(LOC105678648) −0.72 3.01E−04 4.30E−02
LOC105667719 Uncharacterized protein PFB0145c‐like 
(LOC105667719)
−0.81 2.73E−04 4.01E−02
LOC105671848 Putative	exonuclease	GOR	(LOC105671848) −0.82 1.11E−04 2.12E−02
(Continues)
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LOC105674378 Uncharacterized	LOC105674378	(LOC105674378) −0.82 6.36E−04 6.89E−02
LOC105676004 Uncharacterized	LOC105676004	(LOC105676004) −0.82 6.60E−04 7.04E−02
LOC105671329 Insulin‐degrading	enzyme‐like	(LOC105671329) −0.83 7.00E−04 7.13E−02
LOC105672982 Chromosome‐associated kinesin KIF4 
(LOC105672982)
−0.84 3.02E−05 8.75E−03
LOC105670214 Tissue factor pathway inhibitor‐like 
(LOC105670214)
−0.87 9.09E−04 8.86E−02




LOC105667677 Zinc	carboxypeptidase‐like	(LOC105667677) −0.88 6.17E−04 6.82E−02
LOC105670134 Uncharacterized	LOC105670134	(LOC105670134) −0.88 5.08E−04 6.19E−02
LOC105670241 Uncharacterized	LOC105670241	(LOC105670241) −0.89 3.70E−05 9.80E−03
LOC105670430 Aminopeptidase	N‐like	(LOC105670430) −0.91 5.43E−05 1.27E−02
LOC105668482 Espin	(LOC105668482) −0.92 4.39E−04 5.60E−02
LOC105670871 Uncharacterized	LOC105670871	(LOC105670871) −0.92 6.72E−04 7.06E−02
LOC105677706 Bipolar	kinesin	KRP‐130‐like	(LOC105677706) −0.92 4.01E−04 5.24E−02
LOC105678817 Protein	toll‐like	(LOC105678817) −0.94 4.06E−05 1.04E−02
LOC105674728 Muscle M‐line assembly protein unc‐89‐like 
(LOC105674728)
−0.94 1.14E−06 8.71E−04
LOC105678912 Protein	toll‐like	(LOC105678912) −0.94 8.07E−04 8.09E−02
LOC105670239 Uncharacterized	LOC105670239	(LOC105670239) −0.98 4.27E−05 1.05E−02
LOC105678342 Gephyrin‐like	(LOC105678342) −0.99 3.59E−04 4.87E−02
LOC105678985 Uncharacterized	LOC105678985	(LOC105678985) −1.00 1.95E−05 6.35E−03
LOC105670219 Uncharacterized	LOC105670219	(LOC105670219) −1.00 7.05E−04 7.13E−02
LOC105674716 Zinc	carboxypeptidase	A	1‐like	(LOC105674716) −1.01 9.03E−05 1.90E−02
LOC105670899 Uncharacterized	LOC105670899	(LOC105670899) −1.01 3.63E−05 9.80E−03
LOC105678986 Uncharacterized	LOC105678986	(LOC105678986) −1.01 3.51E−04 4.83E−02
LOC105678984 Uncharacterized	LOC105678984	(LOC105678984) −1.02 6.48E−06 3.31E−03
LOC105667907 Thyroid receptor‐interacting protein 11‐like 
(LOC105667907)
−1.02 1.05E−03 9.99E−02
LOC105669733 Venom	carboxylesterase‐6‐like	(LOC105669733) −1.02 1.16E−04 2.14E−02
LOC105678217 Uncharacterized	LOC105678217	(LOC105678217) −1.02 5.44E−05 1.27E−02
LOC105671625 Uncharacterized	LOC105671625	(LOC105671625) −1.06 3.10E−05 8.75E−03
LOC105676578 Thyrotropin‐releasing hormone‐degrading 
ectoenzyme‐like	(LOC105676578)
−1.06 5.30E−04 6.25E−02
LOC105678934 Uncharacterized	LOC105678934	(LOC105678934) −1.06 5.13E−04 6.19E−02
LOC105678987 Uncharacterized	LOC105678987	(LOC105678987) −1.07 2.68E−04 3.99E−02
LOC105675620 Aminopeptidase	N‐like	(LOC105675620) −1.07 2.58E−04 3.96E−02
LOC105674397 Uncharacterized	LOC105674397	(LOC105674397) −1.08 2.38E−05 7.32E−03
LOC105670244 Uncharacterized	LOC105670244	(LOC105670244) −1.10 2.22E−04 3.56E−02
LOC105670868 Uncharacterized	LOC105670868	(LOC105670868) −1.12 3.42E−06 1.93E−03
LOC105674484 RCC1 and BTB domain‐containing protein 1‐like 
(LOC105674484)
−1.14 2.31E−04 3.59E−02
LOC105676597 Uncharacterized	LOC105676597	(LOC105676597) −1.15 1.00E−04 2.03E−02
(Continues)
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LOC105674406 Uncharacterized	LOC105674406	(LOC105674406) −1.17 2.39E−05 7.32E−03
LOC105679050 Transcription termination factor 2‐like 
(LOC105679050)
−1.19 2.05E−07 2.20E−04
LOC105674677 Uncharacterized	LOC105674677	(LOC105674677) −1.20 1.10E−06 8.71E−04
LOC105679162 Uncharacterized	LOC105679162	(LOC105679162) −1.21 1.39E−04 2.48E−02
LOC105672421 Uncharacterized	LOC105672421	(LOC105672421) −1.22 1.02E−04 2.03E−02
LOC105679916 Kinesin‐like	protein	KIF12	(LOC105679916) −1.24 8.97E−06 4.01E−03
LOC105675300 Aminopeptidase	N‐like	(LOC105675300) −1.25 5.16E−04 6.19E−02
LOC105672131 Uncharacterized	LOC105672131	(LOC105672131) −1.26 8.11E−05 1.74E−02
LOC105678936 Uncharacterized	LOC105678936	(LOC105678936) −1.26 2.99E−04 4.30E−02
LOC105670915 Probable	salivary	secreted	peptide	(LOC105670915) −1.29 7.81E−11 1.40E−07
LOC105676006 Uncharacterized	LOC105676006	(LOC105676006) −1.30 1.23E−05 5.08E−03
LOC105668490 Uncharacterized	LOC105668490	(LOC105668490) −1.33 6.14E−04 6.82E−02
LOC105678344 Gephyrin‐like	(LOC105678344) −1.33 1.92E−04 3.11E−02
LOC105671608 Uncharacterized	LOC105671608	(LOC105671608) −1.35 2.62E−04 3.96E−02
LOC105678353 Aminopeptidase	N‐like	(LOC105678353) −1.43 2.18E−06 1.56E−03
LOC105677450 Phosphotriesterase‐related protein‐like 
(LOC105677450)
−1.44 1.15E−04 2.14E−02
LOC105670356 Sodium‐dependent nutrient amino acid transporter 
1‐like	(LOC105670356)
−1.45 1.64E−04 2.79E−02
LOC105679178 Uncharacterized	LOC105679178	(LOC105679178) −1.45 5.80E−04 6.69E−02
LOC105670873 Uncharacterized	LOC105670873	(LOC105670873) −1.45 4.31E−05 1.05E−02
LOC105668011 Uncharacterized	LOC105668011	(LOC105668011) −1.51 2.29E−04 3.59E−02







LOC105674012 Phosphotriesterase‐related protein‐like 
(LOC105674012)
−1.55 1.04E−04 2.03E−02
LOC105676008 Uncharacterized	LOC105676008	(LOC105676008) −1.55 1.57E−05 6.03E−03
LOC105679027 Uncharacterized	LOC105679027	(LOC105679027) −1.58 4.64E−04 5.85E−02
LOC105674893 Uncharacterized	LOC105674893	(LOC105674893) −1.59 3.67E−04 4.89E−02
LOC105673254 Thyrotropin‐releasing hormone‐degrading 
ectoenzyme‐like	(LOC105673254)
−1.60 3.12E−04 4.40E−02




LOC105677676 Aminopeptidase	N‐like	(LOC105677676) −1.67 3.69E−04 4.89E−02
LOC105674526 Uncharacterized	LOC105674526	(LOC105674526) −1.71 8.17E−06 3.81E−03
LOC105677348 Uncharacterized	LOC105677348	(LOC105677348) −1.73 2.80E−15 1.00E−11
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LOC105677480 Uncharacterized	LOC105677480	(LOC105677480) −1.80 6.99E−04 7.13E−02







LOC105679148 Uncharacterized	LOC105679148	(LOC105679148) −1.99 1.59E−08 2.13E−05
LOC105676228 Glutamyl	aminopeptidase‐like	(LOC105676228) −2.02 3.17E−06 1.93E−03
LOC105677332 Uncharacterized	LOC105677332	(LOC105677332) −2.05 2.87E−17 1.54E−13
LOC105675423 Uncharacterized	LOC105675423	(LOC105675423) −2.08 1.51E−05 5.98E−03
LOC105674732 Zinc	carboxypeptidase‐like	(LOC105674732) −2.10 1.60E−04 2.76E−02
LOC105674384 Uncharacterized	LOC105674384	(LOC105674384) −2.11 1.91E−05 6.35E−03
LOC105675063 Alkaline	phosphatase	4‐like	(LOC105675063) −2.13 1.79E−05 6.19E−03











LOC105679017 Uncharacterized	LOC105679017	(LOC105679017) −2.77 6.92E−05 1.51E−02
T4 LOC105679873 Sequestosome‐1	(LOC105679873) 3.08 3.32E−14 4.73E−11
LOC105674352 Aromatic‐l‐amino acid decarboxylase 
(LOC105674352)
3.03 3.71E−13 4.39E−10
LOC105667809 Protein lethal(2)essential for life‐like 
(LOC105667809)
3.02 1.13E−07 5.03E−05
LOC105676758 Ninjurin‐1	(LOC105676758) 2.82 2.79E−07 1.10E−04
LOC105678482 NF‐kappa‐B	inhibitor	cactus‐like	(LOC105678482) 2.78 3.58E−09 2.12E−06
LOC105678050 Uncharacterized	LOC105678050	(LOC105678050) 2.64 8.90E−06 2.48E−03
LOC105675162 Uncharacterized	LOC105675162	(LOC105675162) 2.33 4.34E−06 1.40E−03
LOC105679973 Fatty acid binding protein 1‐B.1‐like 
(LOC105679973)
1.97 1.70E−05 4.33E−03
LOC105674105 Beta‐hexosaminidase subunit beta‐like 
(LOC105674105)
1.92 6.17E−05 1.19E−02







LOC105679392 Vanin‐like	protein	1	(LOC105679392) 1.83 8.62E−06 2.48E−03
LOC105677051 Protein	Malvolio	(LOC105677051) 1.80 2.15E−04 3.56E−02
LOC105676443 Uncharacterized	LOC105676443	(LOC105676443) 1.79 3.88E−05 8.35E−03
LOC105679998 Heat shock 70 kDa protein cognate 4 
(LOC105679998)
1.42 3.74E−04 5.42E−02
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LOC105675281 Fibrillin‐1	(LOC105675281) −1.67 4.31E−04 6.13E−02
LOC105670714 Alpha‐amylase	A	(LOC105670714) −1.78 4.73E−05 9.49E−03
LOC105675053 Cytochrome	P450	6a2‐like	(LOC105675053) −1.79 4.80E−04 6.57E−02
LOC105667318 Dentin	sialophosphoprotein‐like	(LOC105667318) −1.87 2.69E−05 6.21E−03



















LOC105672608 Facilitated trehalose transporter Tret1‐like 
(LOC105672608)
−2.26 1.92E−04 3.32E−02
LOC105671746 Probable	cytochrome	P450	304a1	(LOC105671746) −2.31 6.96E−07 2.61E−04






LOC105671912 Vitellogenin‐1‐like	(LOC105671912) −2.73 5.67E−04 7.62E−02
LOC105678691 Scavenger receptor class B member 1‐like 
(LOC105678691)
−2.75 5.51E−09 3.02E−06
LOC105676041 Uncharacterized	LOC105676041	(LOC105676041) −2.80 4.87E−11 3.85E−08
LOC105674885 Purine nucleoside phosphorylase‐like 
(LOC105674885)
−2.83 9.06E−06 2.48E−03
LOC105674435 Serine protease inhibitor dipetalogastin‐like 
(LOC105674435)
−2.84 2.69E−06 9.12E−04
LOC105677195 Glucose	dehydrogenase	[FAD −2.85 2.71E−05 6.21E−03
LOC105669773 Regucalcin‐like	(LOC105669773) −2.85 1.81E−08 8.60E−06
LOC105668188 Uncharacterized	LOC105668188	(LOC105668188) −2.86 1.41E−08 7.16E−06




LOC105669905 Uncharacterized	LOC105669905	(LOC105669905) −2.95 9.17E−05 1.67E−02




LOC105670441 Uncharacterized	LOC105670441	(LOC105670441) −3.07 1.75E−04 3.11E−02
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LOC105678491 Uncharacterized	LOC105678491	(LOC105678491) −3.67 9.17E−12 8.16E−09
LOC105671873 Uncharacterized	LOC105671873	(LOC105671873) −3.69 1.17E−20 2.78E−17
LOC105677373 Probable WRKY transcription factor protein 1 
(LOC105677373)
−4.04 2.11E−09 1.50E−06
LOC105667550 Uncharacterized	LOC105667550	(LOC105667550) −4.95 4.11E−05 8.60E−03
LOC105671872 Vitellogenin‐2‐like	(LOC105671872) −5.08 2.66E−36 1.89E−32
LOC105669522 Glucose	dehydrogenase	[FAD −5.08 2.89E−05 6.42E−03
LOC105670022 Chymotrypsin‐2‐like	(LOC105670022) −5.18 1.02E−27 3.64E−24
LOC105668189 Uncharacterized	LOC105668189	(LOC105668189) −11.64 4.80E−05 9.49E−03
LOC105670097 Spidroin‐1	(LOC105670097) −13.25 8.03E−04 9.86E−02
T8 LOC105669806 Cytochrome	P450	307a1‐like	(LOC105669806) 1.36 1.15E−07 4.64E−04
LOC105676242 Uncharacterized	LOC105676242	(LOC105676242) 1.31 1.03E−05 1.19E−02
LOC105671866 Serine	protease	gd‐like	(LOC105671866) 1.31 5.74E−06 9.27E−03
LOC105672126 Uncharacterized	LOC105672126	(LOC105672126) 1.09 7.45E−05 6.35E−02
LOC105671608 Uncharacterized	LOC105671608	(LOC105671608) 1.06 1.72E−04 9.96E−02
LOC105674427 Beta‐1,3‐glucan‐binding protein‐like 
(LOC105674427)
1.02 7.86E−05 6.35E−02
LOC105668572 Uncharacterized	LOC105668572	(LOC105668572) 0.91 4.88E−08 3.94E−04








LOC105672608 Facilitated trehalose transporter Tret1‐like 
(LOC105672608)
−0.93 7.57E−06 1.02E−02
LOC105676062 Protein	henna	(LOC105676062) −1.30 4.41E−06 8.90E−03
LOC105668757 Uncharacterized	LOC105668757	(LOC105668757) −2.03 4.17E−07 1.12E−03
T12 LOC105668184 Uncharacterized	LOC105668184	(LOC105668184) 8.58 1.64E−08 8.01E−06
LOC105675287 Major	royal	jelly	protein	1	(LOC105675287) 5.05 1.72E−29 6.14E−26
LOC105670097 Spidroin‐1	(LOC105670097) 3.47 4.32E−04 5.14E−02




LOC105676540 Uncharacterized	LOC105676540	(LOC105676540) 2.86 7.75E−29 2.08E−25
LOC105676242 Uncharacterized	LOC105676242	(LOC105676242) 2.63 3.00E−23 6.44E−20
LOC105670707 Uncharacterized transmembrane protein DDB_
G0289901‐like	(LOC105670707)
2.17 5.77E−45 6.19E−41






LOC105671866 Serine	protease	gd‐like	(LOC105671866) 1.70 4.82E−11 3.44E−08
LOC105672123 Uncharacterized	LOC105672123	(LOC105672123) 1.63 3.02E−05 5.73E−03
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LOC105672608 Facilitated trehalose transporter Tret1‐like 
(LOC105672608)
−0.93 7.57E−06 1.02E−02
LOC105676062 Protein	henna	(LOC105676062) −1.30 4.41E−06 8.90E−03
LOC105668757 Uncharacterized	LOC105668757	(LOC105668757) −2.03 4.17E−07 1.12E−03
T12 LOC105668184 Uncharacterized	LOC105668184	(LOC105668184) 8.58 1.64E−08 8.01E−06
LOC105675287 Major	royal	jelly	protein	1	(LOC105675287) 5.05 1.72E−29 6.14E−26
LOC105670097 Spidroin‐1	(LOC105670097) 3.47 4.32E−04 5.14E−02




LOC105676540 Uncharacterized	LOC105676540	(LOC105676540) 2.86 7.75E−29 2.08E−25
LOC105676242 Uncharacterized	LOC105676242	(LOC105676242) 2.63 3.00E−23 6.44E−20
LOC105670707 Uncharacterized transmembrane protein DDB_
G0289901‐like	(LOC105670707)
2.17 5.77E−45 6.19E−41






LOC105671866 Serine	protease	gd‐like	(LOC105671866) 1.70 4.82E−11 3.44E−08
LOC105672123 Uncharacterized	LOC105672123	(LOC105672123) 1.63 3.02E−05 5.73E−03
LOC105674930 Facilitated trehalose transporter Tret1‐like 
(LOC105674930)
1.60 2.18E−07 8.67E−05
LOC105673362 Limulus	clotting	factor	C‐like	(LOC105673362) 1.55 6.18E−07 2.14E−04
LOC105669469 Cytochrome	b5‐like	(LOC105669469) 1.46 6.81E−13 7.30E−10
LOC105675162 Uncharacterized	LOC105675162	(LOC105675162) 1.46 1.35E−16 2.41E−13
LOC105677051 Protein	Malvolio	(LOC105677051) 1.44 3.83E−12 3.42E−09
LOC105676758 Ninjurin‐1	(LOC105676758) 1.41 1.24E−07 5.10E−05
LOC105678482 NF‐kappa‐B	inhibitor	cactus‐like	(LOC105678482) 1.40 8.63E−16 1.32E−12
LOC105678075 Tyrosine	3‐monooxygenase	(LOC105678075) 1.40 1.51E−13 1.80E−10
LOC105673363 Limulus	clotting	factor	C‐like	(LOC105673363) 1.37 3.02E−09 1.54E−06
LOC105675429 Cyclic	GMP‐AMP	synthase	(LOC105675429) 1.29 5.14E−08 2.29E−05
LOC105677645 Cytochrome	P450	6A1‐like	(LOC105677645) 1.24 9.63E−05 1.54E−02
LOC105677207 Gamma‐glutamyl transpeptidase 1‐like 
(LOC105677207)
1.21 4.40E−12 3.63E−09
LOC105679973 Fatty acid binding protein 1‐B.1‐like 
(LOC105679973)
1.21 3.53E−06 1.02E−03






LOC105672439 Alpha‐sarcoglycan	(LOC105672439) 1.15 6.89E−08 2.95E−05
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LOC105673362 Limulus	clotting	factor	C‐like	(LOC105673362) 1.55 6.18E−07 2.14E−04
LOC105669469 Cytochrome	b5‐like	(LOC105669469) 1.46 6.81E−13 7.30E−10
LOC105675162 Uncharacterized	LOC105675162	(LOC105675162) 1.46 1.35E−16 2.41E−13
LOC105677051 Protein	Malvolio	(LOC105677051) 1.44 3.83E−12 3.42E−09
LOC105676758 Ninjurin‐1	(LOC105676758) 1.41 1.24E−07 5.10E−05
LOC105678482 NF‐kappa‐B	inhibitor	cactus‐like	(LOC105678482) 1.40 8.63E−16 1.32E−12
LOC105678075 Tyrosine	3‐monooxygenase	(LOC105678075) 1.40 1.51E−13 1.80E−10
LOC105673363 Limulus	clotting	factor	C‐like	(LOC105673363) 1.37 3.02E−09 1.54E−06
LOC105675429 Cyclic	GMP‐AMP	synthase	(LOC105675429) 1.29 5.14E−08 2.29E−05
LOC105677645 Cytochrome	P450	6A1‐like	(LOC105677645) 1.24 9.63E−05 1.54E−02
LOC105677207 Gamma‐glutamyl transpeptidase 1‐like 
(LOC105677207)
1.21 4.40E−12 3.63E−09
LOC105679973 Fatty acid binding protein 1‐B.1‐like 
(LOC105679973)
1.21 3.53E−06 1.02E−03






LOC105672439 Alpha‐sarcoglycan	(LOC105672439) 1.15 6.89E−08 2.95E−05
LOC105679722 Uncharacterized	LOC105679722	(LOC105679722) 1.12 5.34E−04 6.10E−02
LOC105678784 Protein	toll‐like	(LOC105678784) 1.11 3.29E−04 4.15E−02
LOC105671850 Protein‐S‐isoprenylcysteine O‐methyltransferase 
(LOC105671850)
1.10 1.57E−05 3.11E−03
LOC105677622 Uncharacterized	LOC105677622	(LOC105677622) 1.08 2.16E−06 6.61E−04
LOC105677585 Venom	protease‐like	(LOC105677585) 1.06 1.20E−05 2.48E−03










LOC105667656 Uncharacterized	LOC105667656	(LOC105667656) 0.98 1.82E−05 3.54E−03
LOC105678551 Uncharacterized	LOC105678551	(LOC105678551) 0.96 4.23E−04 5.12E−02
LOC105676247 Uncharacterized	LOC105676247	(LOC105676247) 0.95 8.77E−06 2.09E−03






LOC105672065 Uncharacterized	LOC105672065	(LOC105672065) 0.91 3.06E−04 4.05E−02
LOC105677172 Protein	dimmed‐like	(LOC105677172) 0.90 9.81E−06 2.19E−03
LOC105675116 Sterol	24‐C‐methyltransferase‐like	(LOC105675116) 0.89 5.33E−05 9.08E−03
LOC105668572 Uncharacterized	LOC105668572	(LOC105668572) 0.89 1.39E−04 2.09E−02
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LOC105668941 Probable citrate synthase 2, mitochondrial 
(LOC105668941)
0.86 3.49E−05 6.23E−03
LOC105669588 Apoptosis‐inducing	factor	3	(LOC105669588) 0.85 2.78E−07 1.03E−04




LOC105677494 Annexin	B9	(LOC105677494) 0.83 7.92E−06 1.97E−03
LOC105670266 Sodium/potassium/calcium exchanger 3‐like 
(LOC105670266)
0.81 9.60E−06 2.19E−03






LOC105678483 NF‐kappa‐B	inhibitor	cactus‐like	(LOC105678483) 0.73 4.25E−04 5.12E−02
LOC105675225 Kelch‐like ECH‐associated protein 1 
(LOC105675225)
0.71 1.28E−04 1.96E−02
LOC105678890 Sodium‐independent sulfate anion transporter 
(LOC105678890)
0.71 7.95E−04 8.44E−02
LOC105673596 Putative inorganic phosphate cotransporter 
(LOC105673596)
0.62 4.03E−04 5.03E−02
LOC105675851 Sphingosine	kinase	2	(LOC105675851) 0.62 7.01E−04 7.66E−02
LOC105677558 Kinectin‐like	(LOC105677558) 0.61 1.64E−04 2.40E−02
LOC105668823 Uncharacterized	LOC105668823	(LOC105668823) 0.61 9.88E−04 9.77E−02
LOC105674043 Uncharacterized	LOC105674043	(LOC105674043) 0.60 2.51E−04 3.54E−02
LOC105671136 Serine	protease	52‐like	(LOC105671136) 0.53 8.59E−04 8.85E−02
LOC105678761 Serine	protease	inhibitor	3/4‐like	(LOC105678761) −0.51 9.14E−04 9.33E−02




LOC105671541 Protein	croquemort‐like	(LOC105671541) −0.68 9.94E−04 9.77E−02
LOC105676100 Tubulin‐specific chaperone cofactor E‐like protein 
(LOC105676100)
−0.71 5.35E−04 6.10E−02
LOC105667678 Monocarboxylate transporter 12‐B 
(LOC105667678)
−0.75 6.13E−04 6.85E−02









LOC105677249 Glycogen‐binding	subunit	76A	(LOC105677249) −0.79 9.57E−05 1.54E−02
LOC105667709 Uncharacterized	LOC105667709	(LOC105667709) −0.79 4.18E−04 5.12E−02
LOC105680137 Tryptophan 2 −0.79 4.02E−05 7.07E−03
LOC105674346 Neural‐cadherin	(LOC105674346) −0.83 3.04E−04 4.05E−02
LOC105670852 Steroid receptor seven‐up, isoforms B/C 
(LOC105670852)
−0.84 1.99E−04 2.84E−02
LOC105678750 Uncharacterized	LOC105678750	(LOC105678750) −0.85 4.64E−04 5.41E−02
LOC105669560 Inositol	oxygenase	(LOC105669560) −0.85 8.16E−06 1.99E−03
(Continues)
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LOC105669509 Arylsulfatase	B‐like	(LOC105669509) −0.92 4.77E−05 8.24E−03
LOC105679739 Uncharacterized	LOC105679739	(LOC105679739) −0.96 5.10E−08 2.29E−05
LOC105672956 Ribose‐phosphate pyrophosphokinase 1 
(LOC105672956)
−0.98 7.94E−04 8.44E−02
LOC105680118 Cysteine	proteinase	1‐like	(LOC105680118) −0.99 3.23E−04 4.12E−02
LOC105677063 Organic	cation	transporter	protein	(LOC105677063) −1.01 1.51E−05 3.06E−03




LOC105671942 Hexokinase‐2‐like	(LOC105671942) −1.04 1.48E−10 9.89E−08
LOC105667318 Dentin	sialophosphoprotein‐like	(LOC105667318) −1.04 3.05E−05 5.73E−03
LOC105680018 Uncharacterized	LOC105680018	(LOC105680018) −1.11 1.16E−05 2.43E−03
LOC105667320 Homeobox	protein	Nkx‐2.2a‐like	(LOC105667320) −1.16 9.78E−04 9.77E−02
LOC105671469 d‐arabinitol	dehydrogenase	1‐like	(LOC105671469) −1.17 2.77E−04 3.86E−02
LOC105671862 Uncharacterized	LOC105671862	(LOC105671862) −1.17 3.35E−05 6.08E−03
LOC105677265 Tachykinin‐like peptides receptor 99D 
(LOC105677265)
−1.25 6.72E−07 2.25E−04
LOC105671615 Zinc	finger	protein	76‐like	(LOC105671615) −1.26 1.12E−05 2.43E−03
LOC105670688 Uncharacterized	LOC105670688	(LOC105670688) −1.32 4.53E−04 5.33E−02
LOC105678416 Pancreatic lipase‐related protein 2‐like 
(LOC105678416)
−1.36 1.73E−11 1.32E−08
LOC105676634 Carboxypeptidase	B‐like	(LOC105676634) −1.39 1.55E−06 4.88E−04
LOC105668871 Phenoloxidase	2‐like	(LOC105668871) −1.42 4.69E−06 1.29E−03
LOC105679484 Sorbitol	dehydrogenase‐like	(LOC105679484) −1.45 1.09E−04 1.70E−02
LOC105675407 Inhibin	beta	E	chain	(LOC105675407) −1.57 1.85E−15 2.47E−12
LOC105670471 Trypsin	epsilon‐like	(LOC105670471) −1.64 1.15E−05 2.43E−03
LOC105678258 Facilitated trehalose transporter Tret1‐like 
(LOC105678258)
−1.87 6.36E−06 1.62E−03
LOC105672897 Cytochrome P450 4C1‐like (pseudo) −1.97 1.08E−09 6.45E−07
LOC105672608 Facilitated trehalose transporter Tret1‐like 
(LOC105672608)
−2.18 1.63E−10 1.03E−07
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